BioLight Life Sciences Ltd.
(TEL Aviv Stock Exchange : BOLT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.71%30.2614.1%$178.05m
AMRNAmarin Corp. Plc -0.75%19.911.7%$159.55m
AXSMAxsome Therapeutics, Inc. -2.31%90.341.9%$129.63m
SAVACassava Sciences, Inc. -4.40%8.250.0%$91.12m
ARQLArQule, Inc. 0.15%20.000.6%$78.96m
BHCBausch Health Cos., Inc. 1.71%30.260.0%$74.96m
SAGESAGE Therapeutics, Inc. 3.12%76.408.6%$70.78m
GWPHGW Pharmaceuticals Plc -0.13%118.976.2%$70.43m
JAZZJazz Pharmaceuticals Plc -0.36%151.052.3%$67.88m
ICPTIntercept Pharmaceuticals, Inc. -3.76%106.1116.9%$63.50m
PRGOPerrigo Co. Plc -0.82%59.026.8%$58.61m
HZNPHorizon Therapeutics Plc 0.29%38.406.6%$57.70m
ENDPEndo International Plc -2.27%6.048.8%$42.46m
ICLRICON plc 0.38%175.784.2%$41.39m
CTLTCatalent, Inc. -1.03%60.842.4%$37.19m

Company Profile

BioLight Life Sciences Ltd. engages in the research, development, and market of pharmaceutical products. It operates through the following segments: Ophthalmic and Micromedic. The Ophthalmic segment distributes topical drugs, surgical systems, and insertable platform under the following brands: Eye-D, IOPtiMate, TeaRx, LIPITEAR, and OphRx. The Micromedic segment specializes in the development and commercialization of innovative in vitro cancer diagnostic products and solutions. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.